A new analysis has found that Hispanic lung cancer patients are at a survival advantage over white or black patients. The study suggests that, along with several other types of cancer, certain undefined genetic and/or environmental factors allow Hispanic patients with lung cancer to live longer than patients of other ethnicities. Results were published April 23 online in Cancer, a peer-reviewed journal of the American Cancer Society.
Researchers determined pain is undertreated in more than one-third of patients with invasive cancer, with minorities twice as likely to not receive analgesics, according to a study published in Journal of Clinical Oncology.
The research from The University of Texas MD Anderson Cancer Center is the largest evaluation of cancer pain and related symptoms ever performed in an outpatient setting.
Researchers from USC recently examined how much cancer patients value hope, particularly with regard to end-of-life treatments.
The study, led by Darius Lakdawalla, director of research at the Schaeffer Center at USC and associate professor in the USC Price School of Public Policy, is published in a unique issue on cancer spending from the journal Health Affairs.
At least 1 treatment-related complication is reported by more than 60% of breast cancer survivors as late as 6 years after their diagnosis, according to a new study published in a special issue of Cancer. Devoted to exploring, preventing, and monitoring the physical late effects of breast cancer treatment, the special issue focuses on the nation’s 2.6 million survivors of the disease.
Relatives of cancer patients experience a large degree of negative stress. Now, researchers say the negative stress increases coronary heart disease and stroke risk by almost 30% for the partners of cancer patients.
In a recent study, researcher Jianguang Ji and colleagues at the Centre for Primary Healthcare Research in Malmö, Sweden, investigated the specific risk for coronary heart disease and stroke when an individual’s spouse is suffering from cancer.
Researchers now believe a connection exists between excess body weight and an increased risk for cancer recurrence in men with clinically localized prostate cancer.
“Men diagnosed with early-stage prostate cancer and who have excess body weight as indicated by a higher-than-normal body mass index (BMI) have an increased risk for cancer recurrence after treatment,” said Vincent L. Freeman, MD, MPH, associate professor in the division of epidemiology and biostatistics in the School of Public Health at the University of Illinois in Chicago, Illinois.
Recent use of an injectable form of progestin-only birth control for a year or more doubles the risk of breast cancer in young women, according to a large-scale US-based study.
“The combination of carboplatin and nab-paclitaxel demonstrates promising efficacy with tolerable toxicity in patients with non-small cell lung cancer (NSCLC) ineligible for therapy with bevacizumab,” said Gregory A. Otterson, MD, professor of internal medicine, co-director of the thoracic oncology program and associate director of the hematology and medical oncology fellowship program at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, Ohio.
Obese, white women may be less likely than their normal-weight peers and African-Americans of any weight or gender to obtain colon cancer screening tests, according to a new study by Johns Hopkins researchers.
To sign up for our newsletter or print publications, please enter your contact information below.
